111 related articles for article (PubMed ID: 37668416)
1. Upregulation of SOX9 promotes the self-renewal and tumorigenicity of cervical cancer through activating the Wnt/β-catenin signaling pathway.
Feng Q; Cui N; Li S; Cao J; Chen Q; Wang H
FASEB J; 2023 Oct; 37(10):e23174. PubMed ID: 37668416
[TBL] [Abstract][Full Text] [Related]
2. LGR6 activates the Wnt/β-catenin signaling pathway and forms a β-catenin/TCF7L2/LGR6 feedback loop in LGR6
Feng Q; Li S; Ma HM; Yang WT; Zheng PS
Oncogene; 2021 Oct; 40(42):6103-6114. PubMed ID: 34489551
[TBL] [Abstract][Full Text] [Related]
3. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
4. Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β-catenin.
Wang Y; Lei L; Zheng YW; Zhang L; Li ZH; Shen HY; Jiang GY; Zhang XP; Wang EH; Xu HT
Cancer Sci; 2018 Jun; 109(6):1799-1810. PubMed ID: 29660200
[TBL] [Abstract][Full Text] [Related]
5. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling.
Leung CO; Mak WN; Kai AK; Chan KS; Lee TK; Ng IO; Lo RC
Oncotarget; 2016 May; 7(20):29371-86. PubMed ID: 27105493
[TBL] [Abstract][Full Text] [Related]
6. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
7. SOX9 and TCF transcription factors associate to mediate Wnt/β-catenin target gene activation in colorectal cancer.
Ramakrishnan AB; Burby PE; Adiga K; Cadigan KM
J Biol Chem; 2023 Jan; 299(1):102735. PubMed ID: 36423688
[TBL] [Abstract][Full Text] [Related]
8. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
9. Repression of Wnt/β-catenin signaling by SOX9 and Mastermind-like transcriptional coactivator 2.
Sinha A; Fan VB; Ramakrishnan AB; Engelhardt N; Kennell J; Cadigan KM
Sci Adv; 2021 Feb; 7(8):. PubMed ID: 33597243
[TBL] [Abstract][Full Text] [Related]
10. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
[TBL] [Abstract][Full Text] [Related]
11. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
[TBL] [Abstract][Full Text] [Related]
12. SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway.
Lu R; Tang P; Zhang D; Lin S; Li H; Feng X; Sun M; Zhang H
Pathol Res Pract; 2023 Aug; 248():154602. PubMed ID: 37315400
[TBL] [Abstract][Full Text] [Related]
13. SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt/β-catenin signaling pathway.
Guo YZ; Xie XL; Fu J; Xing GL
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4898-4907. PubMed ID: 30070325
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of FAM83F by c-Myc promotes cervical cancer growth and aerobic glycolysis via Wnt/β-catenin signaling activation.
Zhang C; Liu L; Li W; Li M; Zhang X; Zhang C; Yang H; Xie J; Pan W; Guo X; She P; Zhong L; Li T
Cell Death Dis; 2023 Dec; 14(12):837. PubMed ID: 38104106
[TBL] [Abstract][Full Text] [Related]
15. Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling.
Xu C; Ding YH; Wang K; Hao M; Li H; Ding L
J Transl Med; 2021 Jul; 19(1):311. PubMed ID: 34281572
[TBL] [Abstract][Full Text] [Related]
16. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
Hsu W; Liu L; Chen X; Zhang Y; Zhu W
Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
[TBL] [Abstract][Full Text] [Related]
17. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
Qi G; Li L
Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
[TBL] [Abstract][Full Text] [Related]
19. Wnt signaling in ovarian development inhibits Sf1 activation of Sox9 via the Tesco enhancer.
Bernard P; Ryan J; Sim H; Czech DP; Sinclair AH; Koopman P; Harley VR
Endocrinology; 2012 Feb; 153(2):901-12. PubMed ID: 22128028
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of galaxamide involved in cell apoptosis and stemness by inhibiting Wnt/β-catenin pathway in cervical cancer.
Yang G; He Y; Chen Y; Huang Z; Huang J; Ren X; Xu S; Li P
Drug Dev Res; 2023 Sep; 84(6):1114-1126. PubMed ID: 37154105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
